NDC Package 0078-0923-61 Kisqali Femara Co-pack

Letrozole And Ribociclib Kit - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0078-0923-61
Package Description:
1 KIT in 1 KIT * 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0078-0881-50) * 21 TABLET in 1 BLISTER PACK (0078-0902-21)
Product Code:
Proprietary Name:
Kisqali Femara Co-pack
Non-Proprietary Name:
Letrozole And Ribociclib
Usage Information:
This product contains 2 medications: ribociclib tablets and letrozole tablets. This product is used to treat breast cancer. Ribociclib works by slowing or stopping the growth of cancer cells. Letrozole works by decreasing the amount of estrogen the body makes, which helps slow down or reverse the growth of some breast cancers.
11-Digit NDC Billing Format:
00078092361
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
  • RxCUI: 153124 - Femara 2.5 MG Oral Tablet
  • RxCUI: 153124 - letrozole 2.5 MG Oral Tablet [Femara]
  • RxCUI: 1873983 - ribociclib 200 MG Oral Tablet
  • RxCUI: 1873983 - ribociclib 200 MG (equivalent to ribociclib succinate 254.4 MG) Oral Tablet
  • RxCUI: 1873989 - Kisqali 200 MG Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Novartis Pharmaceuticals Corporation
    Dosage Form:
    Kit - A packaged collection of related material.
    Sample Package:
    No
    FDA Application Number:
    NDA209935
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    05-04-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0078-0923-61?

    The NDC Packaged Code 0078-0923-61 is assigned to a package of 1 kit in 1 kit * 28 tablet, film coated in 1 bottle, plastic (0078-0881-50) * 21 tablet in 1 blister pack (0078-0902-21) of Kisqali Femara Co-pack, a human prescription drug labeled by Novartis Pharmaceuticals Corporation. The product's dosage form is kit and is administered via form.

    Is NDC 0078-0923 included in the NDC Directory?

    Yes, Kisqali Femara Co-pack with product code 0078-0923 is active and included in the NDC Directory. The product was first marketed by Novartis Pharmaceuticals Corporation on May 04, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0078-0923-61?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units.

    What is the 11-digit format for NDC 0078-0923-61?

    The 11-digit format is 00078092361. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20078-0923-615-4-200078-0923-61